QS ranks MIT the world’s No. 1 university for 2024-25
Ranking at the top for the 13th year in a row, the Institute also places first in 11 subject areas.
Ranking at the top for the 13th year in a row, the Institute also places first in 11 subject areas.
The fellowships provide five years of funding to doctoral students in applied science, engineering, and mathematics who have “the extraordinary creativity and principled leadership necessary to tackle problems others can’t solve.”
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
The Fulbright US Student Program funds research, study, and teaching opportunities abroad.
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
The Institute also ranks second in five subject areas.
Professors Adam Martin and Joel Volman explain the genesis, scope, and objectives of the recently launched Task Force on the MIT Undergraduate Academic Program.
Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
Software allows scientists to model shapeshifting proteins in native cellular environments.
Materials from MIT’s Distinctive Collections reveal stories of women at the Institute.
Nine postdocs and research scientists honored for contributions to the Institute.
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.